FindTrial
Sign In

Effects of a2 receptor agonists on Th1/Th2 cytokine expression in tic disorders

Effects of a2 receptor agonists on Th1/Th2 cytokine expression in tic disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055879
Enrollment
Unknown
Registered
2022-01-22
Start date
2022-02-07
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tic disorders

Interventions

Tourette Syndrome:None
Normal Children:None

Sponsors

Fujan Medical University Union Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1.Tourette's syndrome/Chronic tic disorder patients treatmented with alpha2 agonists; 2.Aged 6 to 12 years; 3.Without co-morbidities.

Exclusion criteria

Exclusion criteria: 1. Patients with other acute and chronic diseases (e.g. acute infection, congenital heart disease, etc.); 2. Patients with other immune system diseases (e.g., systemic lupus erythematosus, etc.).

Design outcomes

Primary

MeasureTime frame
cytokines;—

Countries

China

Contacts

Public ContactKe Zhongling

Fujan Medical University Union Hospital

kzl32@126.com+86 15005019905

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026